Altered Insulin-Like Growth Factor binding Proteins

Simple item page
dc.contributor.assigneeUniversity of Adelaide
dc.contributor.authorForbes, B.
dc.contributor.otherA.P.T. Patent and Trade Mark Attorneys
dc.date.issued2008
dc.descriptionPATENT: B. E. Forbes (Assignee: The University of Adelaide). NZ 537556 (PCT/AU2003/000898) filed Jan. 10, 2005; published Jul. 31, 2008; expires Jul. 11, 2023
dc.description.abstractDisclosed are altered Insulin-like Growth Factor Binding Protein molecules able to effect binding of IGF-I or IGF-II with high affinity characterised in having an inhibited release of IGF on contact with extracellular matrix and exposure to a protease. Also disclosed are nucleic acids encoding the altered IGFBP molecules, a host cell carrying that nucleic acid, and methods of reducing IGF mediated proliferation of a population of cancerous cells.
dc.description.statementofresponsibilityInvented by B. E. Forbes; Assigned to The University of Adelaide; A.P.T. Patent and Trade Mark Attorneys agents for inventor.
dc.identifier.patent537556
dc.identifier.urihttp://hdl.handle.net/2440/74687
dc.language.isoen
dc.source.urihttp://patentscope.wipo.int/search/en/WO2004007543
dc.subjectNZ 537556
dc.titleAltered Insulin-Like Growth Factor binding Proteins
dc.typePatent
pubs.publication-statusPublished

Files

Collections

Molecular and Biomedical Science publications